The AIDS Healthcare Foundation used World Health Day on 7 April to press European governments to back a binding pandemic treaty at the World Health Organization, IOL reported. AHF, an international HIV and public-health group, argued that Europe should lead on a Pathogen Access and Benefit Sharing Annex, the technical schedule that would decide how countries share virus samples and genetic data and how the resulting vaccines and treatments are distributed. Daniel Reijer, the foundation’s Europe bureau chief, said European leaders had “a clear opportunity and responsibility to step forward”. His argument was that richer states elsewhere were pulling back from global health, and that Europe should fill the gap. The appeal landed at a moment when several governments were trimming aid budgets, which sharpened its point about who is left to lead.

What the treaty still lacks

World Health Organization members adopted the Pandemic Agreement in 2025, IOL reported, but the treaty cannot open for signature until the PABS Annex is finished. AHF wants the annex to carry enforceable duties rather than voluntary ones. Its list, as AHF set it out, runs to mandatory benefit-sharing, technology transfers written into binding contracts, equitable access to vaccines, diagnostics and treatments, non-exclusive licences for manufacturers in developing countries during emergencies, and annual financial contributions to the system. Each item, AHF said, is meant to bind commercial users and not only governments. A deadline concentrates the argument. The next World Health Assembly, in May 2026, is the point by which AHF wants the annex settled, and AHF said it would scrutinise the negotiations until then.

The dispute over a dual track

AHF’s sharpest objection is to a proposed hybrid, or “dual-track”, model that it says would let companies reach pathogen data without matching obligations. Such an arrangement, AHF warned, would repeat the failures of the COVID-19 response, when access to vaccines and tests ran far ahead in wealthy countries and lagged elsewhere. COVID-19 also showed how quickly trust between governments breaks when supply is scarce, and AHF’s case is that binding rules, not goodwill, are what hold an agreement together under pressure. Reijer’s foundation framed the fight as one over equity and solidarity, terms it returned to throughout the statement. IOL carried the appeal as AHF’s own, and it reads as advocacy rather than a neutral account of the talks.

Why a pandemic treaty touches medical travel

None of this is medical tourism, and AHF did not present it as such. The connection runs through a standing feature of cross-border care, which is that it depends on two things a pandemic removes at once: open borders and health systems with spare capacity. When those close, patient corridors close with them, and the elective procedures that most medical tourism is made of are the first to be postponed. Oncology, cardiac and fertility patients who cross borders for treatment are exactly the group a closed corridor strands, because their care is planned months ahead and cannot easily move. Those same mechanics were visible on a smaller scale when a regional conflict shut air routes and Gulf patients stopped travelling to Asia, a disruption traced in the collapse of Gulf medical travel to Indian hospitals. A treaty that speeds vaccines and keeps health systems standing in the next outbreak would, on that logic, protect the flows that medical tourism relies on, even though it says nothing about patients who travel to pay for care.

The exposure destinations forget

The point cuts both ways for destinations. A country that markets itself to foreign patients is selling access to its hospitals, and a pandemic turns that access off first for outsiders and last for its own citizens. That is why border-dependent health systems have the most to lose from a weak agreement, and why medical tourism’s exposure to a health emergency belongs on the same risk list as its exposure to conflict. The same reasoning has been applied to war, where analysts watched Middle East turmoil reshape medical tourism along the region’s referral routes. An outbreak can close the same corridors as a war, and usually for longer.

What to watch

The test is a calendar one. Whether the PABS Annex is agreed by the World Health Assembly in May 2026, whether it carries the enforceable benefit-sharing and technology-transfer terms AHF is demanding, and whether Europe rather than the wealthier absentees leads the drafting will all be on the record within the year. AHF gave no sign it would drop the demand if the deadline slipped. A binding pandemic treaty without its annex would, by AHF’s own measure, leave the next outbreak to be managed much as the last one was.